Free University Medical Center
17
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.9%
1 terminated/withdrawn out of 17 trials
87.5%
+1.0% vs industry average
29%
5 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders
Role: lead
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
Role: collaborator
Markers and Response to Cardiac Resynchronization Therapy
Role: collaborator
Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding
Role: collaborator
The PartoMa Project: For Improving Monitoring, Action and Triage During Labour
Role: collaborator
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
Role: collaborator
Understanding Hallucinations (Part I)
Role: collaborator
Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome
Role: collaborator
The Effect of Bezafibrate on Cholestatic Itch
Role: collaborator
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
Role: collaborator
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
Role: collaborator
Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome
Role: collaborator
Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration
Role: lead
Povidone-iodine Antisepsis for Strabismus Surgery
Role: collaborator
Prerecorded Autosuggestion in Long-standing Pain Intervention
Role: lead
Epoprostenol in Pulmonary Embolism
Role: lead
Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Role: lead
All 17 trials loaded